RSS

Felicity Thomas

Felicity Thomas

Felicity Thomas is the editor of EPM Magazine. With over 10 years of B2B publishing experience within various scientific sectors, including analytical sciences and ophthalmology, as well as a Masters Degree in Chemistry with French, her aim is to bring unique and thought-provoking content to the pharma market. She can be reached at felicity.thomas@rapidnews.com 

A brief round-up of some of the developments in the industry including a step in the right direction for oral insulin and an overview of Alantra Pharma’s Fast 50 index… more

Opinion

With worldwide orphan drug sales predicted to grow at a significant rate and each drug fetching a hefty price tag, I look at this market and its drivers in a bit more detail… more

Opinion

A brief round up of some of the developments in the industry, including antibiotic research, curious side effects and the top performing companies. more

Opinion

As the race to dominate the artificial intelligence (AI) space steps up a gear, I take a look at how AI finds use in pharma and how different regions plan to invest in this exciting area. more

Opinion

Despite the ongoing trend in digital tech across the board, pharma is still lagging behind in unlocking the potential of these useful tools… more

Opinion

With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders more

Opinion

As we embark on a difficult flu season, I look at why infection rates vary so much year on year and the potential universal vaccine one company is progressing through the clinical development stages. more

Opinion

Just after Alex Azar has been sworn in as the new Secretary of Health and Human Services under President Trump, many have been asking the question if he will be able to make good on his claim to prioritise the reduction of prescription drug costs more

News

A drug that was believed to be a promising new therapeutic option for suffers of Alzheimer’s (idalopirdine) — from the Danish pharma company, Lundbeck — has failed to show clinical benefit in three randomised trials. more

News

Researchers from Cardiff University, in collaboration with Liverpool John Moores University and AstraZeneca, have developed a new tool to assess the likelihood of a drug undergoing racemisation once inside the body. more

Technology

Oral solid dosage forms are still the preferred method of delivery for the pharma industry but what challenges are encountered and how does the industry solve these potential problems? more

Opinion

With the industry experiencing dramatic change, from regulatory changes to investments in capacity and the uncertainty of the political landscape, we asked several industry heads to review the opportunities, challenges and trends of 2017. more

Opinion

If you are considering a quick winter getaway or some last minute sunshine over the festive period, make sure you check your meds or you may get more than you bargain for… more

Opinion

We have now had a few days to digest the outcome of the relocation vote that took place on Monday 20 November, revealing that the European Medicines Agency (EMA) will be relocated to Amsterdam. But, what should we expect from this relocation? more

News

Today (Monday 20 November) is the day that will see the first vote on the new location of the European Medicines Agency (EMA) be made by European Union (EU) ministers. more

News

The controversy surrounding Avastin and Lucentis has reared its head again as it has been revealed that health chiefs may face a legal fight if they go ahead with plans to offer the cheaper drug (Avastin) to patients with wet AMD on the NHS more

News

Here, we feature a sneak peek preview of some of the companies that will exhibiting at this year’s CPhI event. more

Technology

The September issue of EPM magazine is available for download with all the regulars and features on biologics, drug delivery devices, high potency facilities, digital health and packaging. more

Latest Issue

Apps are ever more popular and becoming part of daily routine and lifestyle in this digital age, but how are pharma companies measuring up in this space? more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News